Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely
investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence …

Nucleic acid-based cancer biomarkers (NABCBs) have emerged as a notable and
continuously captivating research focal point within the domain of oncology. As a result …

BACKGROUND Prostate cancer is the second most frequently diagnosed cancer in men
worldwide. Theranostics, a combination of diagnostics and therapeutics, is an emerging …

Abnormal microRNA (miR) expressions were implicated in prostate cancer progression. We
identified a novel miR-495, which was downregulated in prostate cancer, but not normal …

Prostate cancer (PCa) is the most common non-skin cancer in men worldwide, resulting in
significant mortality and morbidity. Depending on the grade and stage of the cancer, patients …

Background Herein, we identified miRNA signatures that were able to differentiate malignant
prostate cancer from benign prostate hyperplasia and revealed the therapeutic potential of …

Background Currently, no biomarkers are able to differentiate lethal from relatively indolent
prostate cancer (PCa) within high-risk diseases. Nonetheless, several molecules are under …

Разработан метод оценки доли лизированных клеток линии MDA-MB-231, входящих в
состав мультиорганной модели «человек-на-чипе», на основе определения уровня …

Introduction: Prostate cancer is one of the most common malignant diseases in the world,
being the second most common cancer in men worldwide and fifth in terms of mortality. 80 …